Advanced search
Publication Cover
International Journal of Neuroscience Volume 118, 2008 - Issue 1
Submit an article Journal homepage
133
Views
11
CrossRef citations to date
0
Altmetric
Original

THE EFFECT OF ARIPIPRAZOLE ON PREPULSE INHIBITION OF THE STARTLE RESPONSE IN NORMAL AND HYPERDOPAMINERGIC STATES IN RATS

SATORU NAKAI Second Institute of New Drug Discovery, Otsuka Pharmaceutical Co., Ltd., Kagasuno, Kawauchi-cho, Tokushima, Japan
,
TSUYOSHI HIROSE Second Institute of New Drug Discovery, Otsuka Pharmaceutical Co., Ltd., Kagasuno, Kawauchi-cho, Tokushima, Japan
,
TOYOKI MORI Research Institute of Pharmacological & Therapeutical Development, Otsuka Pharmaceutical Co., Ltd., Kagasuno, Kawauchi-cho, Tokushima, Japan
,
ARLENE STARK Neuroscience Drug Discovery, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut, USA
,
HIROAKI ARAKI Division of Hospital Pharmacy, Ehime University Medical School, Shigenobu Onsen-gun, Ehime, Japan
&
TETSURO KIKUCHI Second Institute of New Drug Discovery, Otsuka Pharmaceutical Co., Ltd., Kagasuno, Kawauchi-cho, Tokushima, Japan
Pages 39-57 | Received 26 May 2006, Published online: 24 Aug 2009

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Hugo Geerts, Athan Spiros & Patrick Roberts. (2017) Phosphodiesterase 10 inhibitors in clinical development for CNS disorders. Expert Review of Neurotherapeutics 17:6, pages 553-560.
Read now
Peter Paul De Deyn, Annemieke FJ Drenth, Berry P Kremer, Richard C Oude Voshaar & Debby Van Dam. (2013) Aripiprazole in the treatment of Alzheimer's disease. Expert Opinion on Pharmacotherapy 14:4, pages 459-474.
Read now

Articles from other publishers (9)

Andrea de Bartolomeis, Carmine Tomasetti & Felice Iasevoli. (2015) Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism. CNS Drugs 29:9, pages 773-799.
Crossref
Jamie D. Croxtall. (2012) Aripiprazole. CNS Drugs 26:2, pages 155-183.
Crossref
Adrian Newman-Tancredi & Mark S. Kleven. (2011) Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties. Psychopharmacology 216:4, pages 451-473.
Crossref
Hisae Matsuo, Hiroshi Abe, Tetsuya Ikeda, Kosuke Ebihara, Ryuichiro Takeda, Toshikazu Nishimori & Yasushi Ishida. (2011) Effect of Aripiprazole on Methamphetamine-Induced Disruption of Latent Inhibition in Rats. Journal of Behavioral and Brain Science 01:03, pages 167-171.
Crossref
Taro Kishi, Masatsugu Moriwaki, Tsuyoshi Kitajima, Kunihiro Kawashima, Tomo Okochi, Yasuhisa Fukuo, Osamu Furukawa, Hiroshi Naitoh, Kiyoshi Fujita & Nakao Iwata. (2010) Effect of aripiprazole, risperidone, and olanzapine on the acoustic startle response in Japanese chronic schizophrenia. Psychopharmacology 209:2, pages 185-190.
Crossref
Daisuke Ishii, Daisuke Matsuzawa, Nobuhisa Kanahara, Shingo Matsuda, Chihiro Sutoh, Hiroyuki Ohtsuka, Ken Nakazawa, Mami Kohno, Kenji Hashimoto, Masaomi Iyo & Eiji Shimizu. (2010) Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway. Neuroscience Letters 471:1, pages 53-57.
Crossref
Chantal Schlumberger, Małgorzata Pietraszek, Andreas Gravius, Kai-Uwe Klein, Sergio Greco, Lorenzo Morè & Wojciech Danysz. (2009) Comparison of the mGlu5 receptor positive allosteric modulator ADX47273 and the mGlu2/3 receptor agonist LY354740 in tests for antipsychotic-like activity. European Journal of Pharmacology 623:1-3, pages 73-83.
Crossref
Hugh M. Marston, Jared W. Young, Frederic D. C. Martin, Kevin A. Serpa, Christopher L. Moore, Erik H. F. Wong, Lisa Gold, Leonard T. Meltzer, Marc R. Azar, Mark A. Geyer & Mohammed Shahid. (2009) Asenapine effects in animal models of psychosis and cognitive function. Psychopharmacology 206:4, pages 699-714.
Crossref
T. B. Halene & S. J. Siegel. (2008) Antipsychotic-Like Properties of Phosphodiesterase 4 Inhibitors: Evaluation of 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone (RO-20-1724) with Auditory Event-Related Potentials and Prepulse Inhibition of Startle. Journal of Pharmacology and Experimental Therapeutics 326:1, pages 230-239.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.